Symrise introduces Cellexora™ MD within its Care & Wellness portfolio. The innovative cosmetic ingredient is based on true exosomes, 100% plant-derived (ISO 16128-2) from upcycled organic apple side streams in Italy. This breakthrough marks a new chapter in advanced longevity skincare. Cellexora™ MD enables manufacturers to support deep skin regeneration and long-term vitality while meeting growing consumer expectations for efficacy, transparency, and sustainability. Compared to exosome-inspired or lab-derived alternatives, the Symrise product delivers true extracellular vesicles. Rigorous scientific characterization underpins its high stability, reproducibility, and reliable performance. By addressing multiple hallmarks of skin aging at once, Cellexora™ MD supports premium skincare concepts that go beyond surface correction and focus on skin regeneration.
Setting a new benchmark in advanced well-aging, these plant-derived extracellular vesicles act as biological messengers that facilitate cell-to-cell communication. Through targeted interaction with keratinocytes, fibroblasts, and macrophages, Cellexora™ MD (INCI: Maltodextrin, Malus domestica fruit vesicles) addresses the root causes of skin aging and supports multi-layer skin protection for long-term vitality.
Cellexora™ MD delivers clear, measurable benefits for premium skincare formulations. The ingredient supports collagen production, contributing to visible improvements in skin firmness, elasticity, and resilience. It’s also associated with soothing pathways that help maintain a balanced and comfortable skin environment. In addition, clinical data demonstrate a reduction in visible signs of aging, including wrinkle length, depth, and volume, within 30 days of use.
Formulators can easily utilize the white, odorless powder with 100% natural origin content produced according to ISO 16128-2. High water solubility provides exceptional formulation flexibility and enables seamless integration into almost any skincare application. This combination of performance, versatility, and reliability supports efficient product development and consistent market results.
“These plant-derived exosomes bring nature’s biological intelligence into premium skincare,” says Nathalie Chevrot, Global Skin Care Category Director, Advanced Actives at Symrise. “Cellexora™ MD helps strengthen long-term skin health, vitality and biological function over time. It adds a powerful component to Symrise’s line-up of premium cosmetic ingredients. As consumers increasingly seek true effective skincare beyond correcting visible signs of aging, this innovation helps our customers lead the shift toward healthspan-driven skincare and advanced skin regeneration.”
Symrise will present Cellexora™ MD to the global cosmetics industry at incosmetics Global 2026, taking place from April 14 to 16 in Paris. Visitors can experience the ingredient and explore Symrise’s advanced cosmetic ingredients portfolio of its Care & Wellness Division at Stand 3E10.
